What is she best known for?
The fields of study she is best known for:
Her primary scientific interests are in Genetics, Mutation, Breast cancer, Gene and Cancer.
Her Genetics study frequently intersects with other fields, such as Psychosis.
She combines subjects such as Myosin IIIA, PDZ domain and Actin with her study of Mutation.
Her Breast cancer research incorporates themes from Ovarian cancer and Oncology.
Her Cancer research focuses on subjects like Cancer research, which are linked to CHEK2, Germline, Carcinogenesis, Point mutation and PALB2.
Her Internal medicine study combines topics in areas such as Endocrinology and Pathology.
Her most cited work include:
- Strong Association of De Novo Copy Number Mutations with Autism (2404 citations)
- Evolution at two levels in humans and chimpanzees (2366 citations)
- Linkage of early-onset familial breast cancer to chromosome 17q21 (2088 citations)
What are the main themes of her work throughout her whole career to date?
Her scientific interests lie mostly in Genetics, Breast cancer, Gene, Internal medicine and Cancer.
Her Genetics study typically links adjacent topics like Hearing loss.
Her research on Breast cancer also deals with topics like
- Ovarian cancer that intertwine with fields like Tumor suppressor gene,
- Cancer research which connect with Germline.
The various areas that Mary Claire King examines in her Internal medicine study include Endocrinology and Oncology.
Her study in Germline mutation extends to Cancer with its themes.
Her Allele research is multidisciplinary, relying on both Immunology and Genotype.
She most often published in these fields:
- Genetics (54.67%)
- Breast cancer (22.80%)
- Gene (21.98%)
What were the highlights of her more recent work (between 2016-2021)?
- Genetics (54.67%)
- Internal medicine (20.05%)
- Gene (21.98%)
In recent papers she was focusing on the following fields of study:
Her primary areas of study are Genetics, Internal medicine, Gene, Mutation and Oncology.
Her Genetics study is mostly concerned with Allele, Exon, Germline mutation, Missense mutation and Germline.
Her Gene study incorporates themes from Schizophrenia and Evolutionary biology.
Her research investigates the connection between Mutation and topics such as Loss of heterozygosity that intersect with problems in Microsatellite instability, PMS2 and Tumor suppressor gene.
Her Oncology research includes elements of Odds ratio, Cancer, Breast cancer, Dynamic contrast and Cohort.
As a member of one scientific family, Mary Claire King mostly works in the field of Breast cancer, focusing on Ovarian cancer and, on occasion, Aunt and Gynecology.
Between 2016 and 2021, her most popular works were:
- Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study. (89 citations)
- Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy (57 citations)
- Inherited Breast Cancer in Nigerian Women (40 citations)
In her most recent research, the most cited papers focused on:
Her main research concerns Genetics, Internal medicine, Oncology, Mutation and Cancer.
Genetics and Schizophrenia are commonly linked in her work.
She interconnects Lynch syndrome and Familial adenomatous polyposis in the investigation of issues within Oncology.
Her studies deal with areas such as Glycosylation and Microsatellite instability as well as Mutation.
The study incorporates disciplines such as Ashkenazi jews, Dynamic contrast and Cohort in addition to Cancer.
Her work carried out in the field of Breast cancer brings together such families of science as CHEK2, Ovarian cancer and Family history.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
